https://scholars.lib.ntu.edu.tw/handle/123456789/494979
標題: | LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results | 作者: | CHIH-HSIN YANG Ramalingam S.S Jänne P.A Cantarini M Mitsudomi T. |
公開日期: | 2016 | 出版社: | Elsevier Inc | 卷: | 11 | 期: | 4 | 起(迄)頁: | S152-S153 | 來源出版物: | Journal of Thoracic Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85000962707&doi=10.1016%2fS1556-0864%2816%2930325-2&partnerID=40&md5=d26b7c39d8c5ed825a5605003ddaed32 https://scholars.lib.ntu.edu.tw/handle/123456789/494979 |
ISSN: | 1556-0864 | DOI: | 10.1016/S1556-0864(16)30325-2 | SDG/關鍵字: | osimertinib; advanced cancer; Article; brain metastasis; cancer chemotherapy; cancer survival; causal attribution; clinical effectiveness; diarrhea; drug efficacy; drug safety; human; major clinical study; non small cell lung cancer; outcome assessment; phase 1 clinical trial; phase 2 clinical trial; population research; priority journal; progression free survival; rash; survival time |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。